Genelux Corporation: A Speculative Buy Worth Considering? In the volatile world of biotech investments, pinpointing potential high-reward stocks can be akin to finding a needle in a haystack. Yet, the recent analysis by Benchmark on Genelux Corporation (Ticker Symbol: GNLX) has caught the attention of many in the industry. With a reiterated speculative buy rating and a staggering price target of $30—nearly six times its current trading pri...
Genelux股票討論區
$Healthy Choice Wellness (HCWC.US)$ 第二天的漲勢。我買入價為5.15。
$Kairos Pharma (KAPA.US)$ 同時,我買入價為2.25。
$Knightscope (KSCP.US)$ 進行回拋後,空頭持倉非常高。我打算在開盤時買入,目標是7.75。
計劃在今天結束時達到綠色並增長40%。
Genelux 股份有限公司公佈 2024 年第二季財務業績並提供一般業務更新
日內盧(納斯達克:GNLX)公佈了 2024 年第二季財務業績並提供業務更新。該公司完成了 30 萬美元的公開發售,並通過三次試用讀數提供了跑道。Genelux 預計到 2025 年中期在復發非小細胞肺癌的第二期試驗中期結果,以及在復發性小細胞的 10 億期試驗中期數據...
更大圖片: 交易視圖
$Genelux (GNLX.US)$
In the volatile world of biotech investments, pinpointing potential high-reward stocks can be akin to finding a needle in a haystack. Yet, the recent analysis by Benchmark on Genelux Corporation (Ticker Symbol: GNLX) has caught the attention of many in the industry. With a reiterated speculative buy rating and a staggering price target of $30—nearly six times its current trading pri...
7天內從35美元跌至20美元
錯過了我的進場點
暫無評論